Inventor · disambiguated record
Qinghua Mao
Also filed as: MAO QINGHUA
11 granted patents·3 pending applications·8 citations·filing 2014–2022
79Inventor score
Files withMERCK SHARP & DOHME6DONGBAO PURPLE STAR HANGZHOU BIOPHARMACEUTICAL CO LTD2MEDSHINE DISCOVERY INC2SHANDONG DANHONG PHARMACEUTICAL CO LTD2CGENETECH SUZHOU CHINA CO LTD1
Top patents by PatentIndex Score
14 records- 0186US9815846B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2015·Granted Nov 14, 2017·8 cites·16 claims
- 0260US2025122190A1Halogen-substituted pyridazinone compound and application thereofMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 0354US10822365B1SGLTS inhibitor and application thereofSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 3, 2020·0 cites·13 claims
- 0453US2024368178A1Imidazocyclic compound and application thereofDONGBAO PURPLE STAR HANGZHOU BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0550US12421269B2SGLT2/DPP4 inhibitor and application thereofCGENETECH SUZHOU CHINA CO LTD·Filed 2020·Granted Sep 23, 2025·0 cites·9 claims
- 0650US12258367B2Glucoside derivative that acts as SGLT1 inhibitor and application thereofMEDSHINE DISCOVERY INC·Filed 2020·Granted Mar 25, 2025·0 cites·17 claims
- 0746US9896447B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2014·Granted Feb 20, 2018·0 cites·9 claims
- 0846US9718782B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2014·Granted Aug 1, 2017·0 cites·10 claims
- 0944US12378277B2SGLTS/DPP4 inhibitor and application thereofDONGBAO PURPLE STAR HANGZHOU BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Aug 5, 2025·0 cites·17 claims
- 1043US2022324897A1Crystal form of sglt inhibitor and application thereofSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1141US9862716B2TRKA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2015·Granted Jan 9, 2018·0 cites·16 claims
- 1240US11021486B2Coumarin-like cyclic compound as MEK inhibitor and use thereofCSTONE PHARMACEUTICALS·Filed 2018·Granted Jun 1, 2021·0 cites·24 claims
- 1340US9862707B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2015·Granted Jan 9, 2018·0 cites·24 claims
- 1436US9914736B2TrKA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2015·Granted Mar 13, 2018·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Qinghua Mao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →